1 Viral Conjunctivitis Pipeline Drugs Introduction and Market Overview 1.1 Objectives of the Study 1.2 Definition of Viral Conjunctivitis Pipeline Drugs 1.3 Viral Conjunctivitis Pipeline Drugs Market Scope and Market Size Estimation 1.3.1 Market Concentration Ratio and Market Maturity Analysis 1.3.2 Europe Viral Conjunctivitis Pipeline Drugs Value and Growth Rate from 2014-2024 1.4 Market Segmentation 1.4.1 Types of Viral Conjunctivitis Pipeline Drugs 1.4.2 Applications of Viral Conjunctivitis Pipeline Drugs 1.4.3 Research Countries 1.5 Market Dynamics 1.5.1 Drivers 1.5.2 Limitations 1.5.3 Opportunities 1.6 Industry News and Policies by Countries 1.6.1 Industry News 1.6.2 Industry Policies 2 Industry Chain Analysis 2.1 Upstream Raw Material Suppliers of Viral Conjunctivitis Pipeline Drugs Analysis 2.2 Major Players of Viral Conjunctivitis Pipeline Drugs 2.2.1 Major Players Manufacturing Base and Market Share of Viral Conjunctivitis Pipeline Drugs in 2018 2.2.2 Major Players Product Types in 2018 2.3 Viral Conjunctivitis Pipeline Drugs Manufacturing Cost Structure Analysis 2.3.1 Consumption Process Analysis 2.3.2 Manufacturing Cost Structure of Viral Conjunctivitis Pipeline Drugs 2.3.3 Raw Material Cost of Viral Conjunctivitis Pipeline Drugs 2.3.4 Labor Cost of Viral Conjunctivitis Pipeline Drugs 2.4 Market Channel Analysis of Viral Conjunctivitis Pipeline Drugs 2.5 Major Downstream Buyers of Viral Conjunctivitis Pipeline Drugs Analysis 3 Europe Viral Conjunctivitis Pipeline Drugs Market, by Type 3.1 Europe Viral Conjunctivitis Pipeline Drugs Value and Market Share by Type (2014-2019E) 3.2 Europe Viral Conjunctivitis Pipeline Drugs Consumption and Market Share by Type (2014-2019E) 3.3 Europe Viral Conjunctivitis Pipeline Drugs Value and Growth Rate by Type (2014-2019E) 3.3.1 Europe Viral Conjunctivitis Pipeline Drugs Value and Growth Rate of FST-100 3.3.2 Europe Viral Conjunctivitis Pipeline Drugs Value and Growth Rate of APD-209 3.4 Europe Viral Conjunctivitis Pipeline Drugs Price Analysis by Type (2014-2019E) 4 Viral Conjunctivitis Pipeline Drugs Market, by Application 4.1 Downstream Market Overview 4.2 Europe Viral Conjunctivitis Pipeline Drugs Consumption and Market Share by Application (2014-2019E) 4.2.1 Europe Viral Conjunctivitis Pipeline Drugs Consumption and Growth Rate of Hospitals (2014-2019E) 4.2.2 Europe Viral Conjunctivitis Pipeline Drugs Consumption and Growth Rate of Clinics (2014-2019E) 4.2.3 Europe Viral Conjunctivitis Pipeline Drugs Consumption and Growth Rate of Others (2014-2019E) 5 Europe Viral Conjunctivitis Pipeline Drugs Consumption, Value ($) by Countries (2014-2019E) 5.1 Europe Viral Conjunctivitis Pipeline Drugs Value and Market Share by Countries (2014-2019E) 5.2 Europe Viral Conjunctivitis Pipeline Drugs Consumption and Market Share by Countries (2014-2019E) 5.3 Europe Viral Conjunctivitis Pipeline Drugs Consumption, Value, Price and Gross Margin (2014-2019E) 5.4 Germany Viral Conjunctivitis Pipeline Drugs Consumption, Value, Price and Gross Margin (2014-2019E) 5.5 UK Viral Conjunctivitis Pipeline Drugs Consumption, Value, Price and Gross Margin (2014-2019E) 5.6 France Viral Conjunctivitis Pipeline Drugs Consumption, Value, Price and Gross Margin (2014-2019E) 5.7 Italy Viral Conjunctivitis Pipeline Drugs Consumption, Value, Price and Gross Margin (2014-2019E) 5.8 Spain Viral Conjunctivitis Pipeline Drugs Consumption, Value, Price and Gross Margin (2014-2019E) 5.9 Russia Viral Conjunctivitis Pipeline Drugs Consumption, Value, Price and Gross Margin (2014-2019E) 6 Competitive Landscape 6.1 Competitive Profile 6.2 NovaBay Pharmaceuticals, Inc. 6.2.1 Company Profiles 6.2.2 Viral Conjunctivitis Pipeline Drugs Product Introduction 6.2.3 NovaBay Pharmaceuticals, Inc. Sales, Value, Price, Gross Margin 2014-2019E 6.2.4 NovaBay Pharmaceuticals, Inc. Market Share of Viral Conjunctivitis Pipeline Drugs Segmented by Region in 2018 6.3 Marinomed Biotechnologie GmbH 6.3.1 Company Profiles 6.3.2 Viral Conjunctivitis Pipeline Drugs Product Introduction 6.3.3 Marinomed Biotechnologie GmbH Sales, Value, Price, Gross Margin 2014-2019E 6.3.4 Marinomed Biotechnologie GmbH Market Share of Viral Conjunctivitis Pipeline Drugs Segmented by Region in 2018 6.4 NicOx S.A. 6.4.1 Company Profiles 6.4.2 Viral Conjunctivitis Pipeline Drugs Product Introduction 6.4.3 NicOx S.A. Sales, Value, Price, Gross Margin 2014-2019E 6.4.4 NicOx S.A. Market Share of Viral Conjunctivitis Pipeline Drugs Segmented by Region in 2018 6.5 Novartis AG 6.5.1 Company Profiles 6.5.2 Viral Conjunctivitis Pipeline Drugs Product Introduction 6.5.3 Novartis AG Sales, Value, Price, Gross Margin 2014-2019E 6.5.4 Novartis AG Market Share of Viral Conjunctivitis Pipeline Drugs Segmented by Region in 2018 6.6 Adenovir Pharma AB 6.6.1 Company Profiles 6.6.2 Viral Conjunctivitis Pipeline Drugs Product Introduction 6.6.3 Adenovir Pharma AB Sales, Value, Price, Gross Margin 2014-2019E 6.6.4 Adenovir Pharma AB Market Share of Viral Conjunctivitis Pipeline Drugs Segmented by Region in 2018 6.7 Starpharma Holdings Ltd. 6.7.1 Company Profiles 6.7.2 Viral Conjunctivitis Pipeline Drugs Product Introduction 6.7.3 Starpharma Holdings Ltd. Sales, Value, Price, Gross Margin 2014-2019E 6.7.4 Starpharma Holdings Ltd. Market Share of Viral Conjunctivitis Pipeline Drugs Segmented by Region in 2018 6.8 Panoptes Pharma GES.M.B.H. 6.8.1 Company Profiles 6.8.2 Viral Conjunctivitis Pipeline Drugs Product Introduction 6.8.3 Panoptes Pharma GES.M.B.H. Sales, Value, Price, Gross Margin 2014-2019E 6.8.4 Panoptes Pharma GES.M.B.H. Market Share of Viral Conjunctivitis Pipeline Drugs Segmented by Region in 2018 6.9 Allergan plc 6.9.1 Company Profiles 6.9.2 Viral Conjunctivitis Pipeline Drugs Product Introduction 6.9.3 Allergan plc Sales, Value, Price, Gross Margin 2014-2019E 6.9.4 Allergan plc Market Share of Viral Conjunctivitis Pipeline Drugs Segmented by Region in 2018 6.10 NanoViricides, Inc. 6.10.1 Company Profiles 6.10.2 Viral Conjunctivitis Pipeline Drugs Product Introduction 6.10.3 NanoViricides, Inc. Sales, Value, Price, Gross Margin 2014-2019E 6.10.4 NanoViricides, Inc. Market Share of Viral Conjunctivitis Pipeline Drugs Segmented by Region in 2018 6.11 Shire plc 6.11.1 Company Profiles 6.11.2 Viral Conjunctivitis Pipeline Drugs Product Introduction 6.11.3 Shire plc Sales, Value, Price, Gross Margin 2014-2019E 6.11.4 Shire plc Market Share of Viral Conjunctivitis Pipeline Drugs Segmented by Region in 2018 7 Europe Viral Conjunctivitis Pipeline Drugs Market Analysis and Forecast by Type and Application 7.1 Europe Viral Conjunctivitis Pipeline Drugs Market Value & Volume Forecast, by Type (2019-2024) 7.1.1 FST-100 Market Value and Volume Forecast (2019-2024) 7.1.2 APD-209 Market Value and Volume Forecast (2019-2024) 7.2 Europe Viral Conjunctivitis Pipeline Drugs Market Value & Volume Forecast, by Application (2019-2024) 7.2.1 Hospitals Market Value and Volume Forecast (2019-2024) 7.2.2 Clinics Market Value and Volume Forecast (2019-2024) 7.2.3 Others Market Value and Volume Forecast (2019-2024) 8 Viral Conjunctivitis Pipeline Drugs Market Analysis and Forecast by Countries 8.1 Germany Market Value and Consumption Forecast (2019-2024) 8.2 UK Market Value and Consumption Forecast (2019-2024) 8.3 France Market Value and Consumption Forecast (2019-2024) 8.4 Italy Market Value and Consumption Forecast (2019-2024) 8.5 Spain Market Value and Consumption Forecast (2019-2024) 8.6 Russia Market Value and Consumption Forecast (2019-2024) 9 New Project Feasibility Analysis 9.1 Industry Barriers and New Entrants SWOT Analysis 9.2 Analysis and Suggestions on New Project Investment 10 Research Finding and Conclusion 11 Appendix 11.1 Methodology 11.2 Research Data Source

List of Tables and Figures Figure Product Picture of Viral Conjunctivitis Pipeline Drugs Table Product Specification of Viral Conjunctivitis Pipeline Drugs Figure Market Concentration Ratio and Market Maturity Analysis of Viral Conjunctivitis Pipeline Drugs Figure Europe Viral Conjunctivitis Pipeline Drugs Value ($) and Growth Rate from 2014-2024 Table Different Types of Viral Conjunctivitis Pipeline Drugs Figure Europe Viral Conjunctivitis Pipeline Drugs Value ($) Segment by Type from 2014-2019E Figure Europe Viral Conjunctivitis Pipeline Drugs Market Share by Types in 2018 Figure FST-100 Picture Figure APD-209 Picture Table Different Applications of Viral Conjunctivitis Pipeline Drugs Figure Europe Viral Conjunctivitis Pipeline Drugs Value ($) Segment by Applications from 2014-2019E Figure Europe Viral Conjunctivitis Pipeline Drugs Market Share by Applications in 2018 Figure Hospitals Picture Figure Clinics Picture Figure Others Picture Table Research Countries of Viral Conjunctivitis Pipeline Drugs Figure Europe Viral Conjunctivitis Pipeline Drugs Market Share by Countries in 2018 Figure Germany Viral Conjunctivitis Pipeline Drugs Consumption Value ($) and Growth Rate (2014-2019E) Figure UK Viral Conjunctivitis Pipeline Drugs Consumption Value ($) and Growth Rate (2014-2019E) Figure France Viral Conjunctivitis Pipeline Drugs Consumption Value ($) and Growth Rate (2014-2019E) Figure Italy Viral Conjunctivitis Pipeline Drugs Consumption Value ($) and Growth Rate (2014-2019E) Figure Spain Viral Conjunctivitis Pipeline Drugs Consumption Value ($) and Growth Rate (2014-2019E) Figure Russia Viral Conjunctivitis Pipeline Drugs Consumption Value ($) and Growth Rate (2014-2019E) Table Emerging and Growing Market of Viral Conjunctivitis Pipeline Drugs Table Industry News Table Industry Policies Figure Industry Chain Analysis of Viral Conjunctivitis Pipeline Drugs Table Upstream Raw Material Suppliers of Viral Conjunctivitis Pipeline Drugs with Contact Information Table Major Players Manufacturing Base and Market Share of Viral Conjunctivitis Pipeline Drugs in 2018 Table Major Players Consumption Value Market Share of Viral Conjunctivitis Pipeline Drugs in 2018 Table Major Players Viral Conjunctivitis Pipeline Drugs Product Types in 2018 Figure Consumption Process of Viral Conjunctivitis Pipeline Drugs Figure Manufacturing Cost Structure of Viral Conjunctivitis Pipeline Drugs Figure Channel Status of Viral Conjunctivitis Pipeline Drugs Table Major Distributors of Viral Conjunctivitis Pipeline Drugs with Contact Information Table Major Downstream Buyers of Viral Conjunctivitis Pipeline Drugs with Contact Information Table Europe Viral Conjunctivitis Pipeline Drugs Value ($) by Type (2014-2019E) Table Europe Viral Conjunctivitis Pipeline Drugs Value Share by Type (2014-2019E) Figure Europe Viral Conjunctivitis Pipeline Drugs Value Share by Type (2014-2019E) Table Europe Viral Conjunctivitis Pipeline Drugs Consumption by Type (2014-2019E) Table Europe Viral Conjunctivitis Pipeline Drugs Consumption Share by Type (2014-2019E) Figure Europe Viral Conjunctivitis Pipeline Drugs Consumption Share by Type (2014-2019E) Figure FST-100 Picture Figure APD-209 Picture Figure Europe Viral Conjunctivitis Pipeline Drugs Value ($) and Growth Rate of APD-209 Table Europe Viral Conjunctivitis Pipeline Drugs Price by Type (2014-2019E) Figure Downstream Market Overview Table Europe Viral Conjunctivitis Pipeline Drugs Consumption by Application (2014-2019E) Table Europe Viral Conjunctivitis Pipeline Drugs Consumption Market Share by Application (2014-2019E) Figure Europe Viral Conjunctivitis Pipeline Drugs Consumption Market Share by Application (2014-2019E) Figure Europe Viral Conjunctivitis Pipeline Drugs Consumption and Growth Rate of Hospitals (2014-2019) Figure Europe Viral Conjunctivitis Pipeline Drugs Consumption and Growth Rate of Clinics (2014-2019) Figure Europe Viral Conjunctivitis Pipeline Drugs Consumption and Growth Rate of Others (2014-2019) Table Europe Viral Conjunctivitis Pipeline Drugs Value ($) by Countries (2014-2019E) Table Europe Viral Conjunctivitis Pipeline Drugs Value Market Share by Countries (2014-2019E) Figure Europe Viral Conjunctivitis Pipeline Drugs Value Market Share by Countries (2014-2019E) Table Europe Viral Conjunctivitis Pipeline Drugs Consumption by Countries (2014-2019E) Table Europe Viral Conjunctivitis Pipeline Drugs Consumption Market Share by Countries (2014-2019E) Figure Europe Viral Conjunctivitis Pipeline Drugs Consumption Market Share by Countries (2014-2019E) Table Europe Viral Conjunctivitis Pipeline Drugs Consumption, Value, Price and Gross Margin (2014-2019E) Table Germany Viral Conjunctivitis Pipeline Drugs Consumption, Value, Price and Gross Margin (2014-2019E) Table UK Viral Conjunctivitis Pipeline Drugs Consumption, Value, Price and Gross Margin (2014-2019E) Table France Viral Conjunctivitis Pipeline Drugs Consumption, Value, Price and Gross Margin (2014-2019E) Table Italy Viral Conjunctivitis Pipeline Drugs Consumption, Value, Price and Gross Margin (2014-2019E) Table Spain Viral Conjunctivitis Pipeline Drugs Consumption, Value, Price and Gross Margin (2014-2019E) Table Russia Viral Conjunctivitis Pipeline Drugs Consumption, Value, Price and Gross Margin (2014-2019E) Figure Top 3 Market Share of Viral Conjunctivitis Pipeline Drugs Companies in 2018 Figure Top 6 Market Share of Viral Conjunctivitis Pipeline Drugs Companies in 2018 Table Major Players Value ($) Share (2014-2019E) Table Company Profiles Table Product Introduction Table NovaBay Pharmaceuticals, Inc. Sales, Value, Price, Gross Margin 2014-2019E Figure NovaBay Pharmaceuticals, Inc. Sales and Growth Rate Figure NovaBay Pharmaceuticals, Inc. Value ($) Market Share 2014-2019 Figure NovaBay Pharmaceuticals, Inc. Market Share of Viral Conjunctivitis Pipeline Drugs Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Marinomed Biotechnologie GmbH Sales, Value, Price, Gross Margin 2014-2019E Figure Marinomed Biotechnologie GmbH Sales and Growth Rate Figure Marinomed Biotechnologie GmbH Value ($) Market Share 2014-2019 Figure Marinomed Biotechnologie GmbH Market Share of Viral Conjunctivitis Pipeline Drugs Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table NicOx S.A. Sales, Value, Price, Gross Margin 2014-2019E Figure NicOx S.A. Sales and Growth Rate Figure NicOx S.A. Value ($) Market Share 2014-2019 Figure NicOx S.A. Market Share of Viral Conjunctivitis Pipeline Drugs Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Novartis AG Sales, Value, Price, Gross Margin 2014-2019E Figure Novartis AG Sales and Growth Rate Figure Novartis AG Value ($) Market Share 2014-2019 Figure Novartis AG Market Share of Viral Conjunctivitis Pipeline Drugs Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Adenovir Pharma AB Sales, Value, Price, Gross Margin 2014-2019E Figure Adenovir Pharma AB Sales and Growth Rate Figure Adenovir Pharma AB Value ($) Market Share 2014-2019 Figure Adenovir Pharma AB Market Share of Viral Conjunctivitis Pipeline Drugs Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Starpharma Holdings Ltd. Sales, Value, Price, Gross Margin 2014-2019E Figure Starpharma Holdings Ltd. Sales and Growth Rate Figure Starpharma Holdings Ltd. Value ($) Market Share 2014-2019 Figure Starpharma Holdings Ltd. Market Share of Viral Conjunctivitis Pipeline Drugs Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Panoptes Pharma GES.M.B.H. Sales, Value, Price, Gross Margin 2014-2019E Figure Panoptes Pharma GES.M.B.H. Sales and Growth Rate Figure Panoptes Pharma GES.M.B.H. Value ($) Market Share 2014-2019 Figure Panoptes Pharma GES.M.B.H. Market Share of Viral Conjunctivitis Pipeline Drugs Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Allergan plc Sales, Value, Price, Gross Margin 2014-2019E Figure Allergan plc Sales and Growth Rate Figure Allergan plc Value ($) Market Share 2014-2019 Figure Allergan plc Market Share of Viral Conjunctivitis Pipeline Drugs Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table NanoViricides, Inc. Sales, Value, Price, Gross Margin 2014-2019E Figure NanoViricides, Inc. Sales and Growth Rate Figure NanoViricides, Inc. Value ($) Market Share 2014-2019 Figure NanoViricides, Inc. Market Share of Viral Conjunctivitis Pipeline Drugs Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Shire plc Sales, Value, Price, Gross Margin 2014-2019E Figure Shire plc Sales and Growth Rate Figure Shire plc Value ($) Market Share 2014-2019 Figure Shire plc Market Share of Viral Conjunctivitis Pipeline Drugs Segmented by Region in 2018 Table Europe Viral Conjunctivitis Pipeline Drugs Market Value ($) Forecast, by Type Table Europe Viral Conjunctivitis Pipeline Drugs Market Volume Forecast, by Type Table Europe Market Value ($) Forecast by Application (2019-2024) Table Europe Market Volume Forecast by Application (2019-2024) Figure Germany Market Value ($) and Growth Rate Forecast (2019-2024) Figure Germany Consumption and Growth Rate Forecast (2019-2024) Figure UK Market Value ($) and Growth Rate Forecast (2019-2024) Figure UK Consumption and Growth Rate Forecast (2019-2024) Figure France Market Value ($) and Growth Rate Forecast (2019-2024) Figure France Consumption and Growth Rate Forecast (2019-2024) Figure Italy Market Value ($) and Growth Rate Forecast (2019-2024) Figure Italy Consumption and Growth Rate Forecast (2019-2024) Figure Spain Market Value ($) and Growth Rate Forecast (2019-2024) Figure Spain Consumption and Growth Rate Forecast (2019-2024) Figure Russia Market Value ($) and Growth Rate Forecast (2019-2024) Figure Russia Consumption and Growth Rate Forecast (2019-2024) Figure Industry Resource/Technology/Labor Importance Analysis Table New Entrants SWOT Analysis Table New Project Analysis of Investment Recovery